Recurrent Immune Thrombocytopenia in a 71-Year-Old Woman Following Moderna COVID 19 Vaccination. The Need for Close Clinical and Biological Monitoring
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.